Copyright
©The Author(s) 2024.
World J Gastroenterol. Apr 28, 2024; 30(16): 2258-2271
Published online Apr 28, 2024. doi: 10.3748/wjg.v30.i16.2258
Published online Apr 28, 2024. doi: 10.3748/wjg.v30.i16.2258
Table 1 Disease activity index (0-5)
| Parameters | Scores |
| Weight loss | 0: No; 1: < 10%; 2: ≥ 10% |
| Stool consistency | 0: Regular; 1: Soft; 2: Diarrhea |
| Blood occurrence | 0: Absence; 1: Presence |
Table 2 Histological score (0-18)
| Parameters | Score | Description |
| Severity of inflammation | 0 | None |
| 1 | Slight | |
| 2 | Moderate | |
| 3 | Severe | |
| Extent | 0 | None |
| 1 | Mucosa | |
| 2 | Mucosa and submucosa | |
| 3 | Transmural | |
| Regeneration | 4 | No tissue repair |
| 3 | Surface epithelium not intact | |
| 2 | Regeneration with crypt depletion | |
| 1 | Almost complete regeneration | |
| 0 | Complete regeneration or normal tissue | |
| Crypt damage | 0 | None |
| 1 | Basal 1/3 damaged | |
| 2 | Basal 2/3 damaged | |
| 3 | Only surface epithelium intact | |
| 4 | Entire crypt and epithelium lost | |
| Involvement | 1 | 1%-25% |
| 2 | 26%-50% | |
| 3 | 51%-75% | |
| 4 | 76%-100% |
Table 3 Sequences of the primers
| Human genes | Primer sequences (5’-3’) |
| GAPDH | F: 5’-GAC ACC CAC TCC TCC ACC TTT-3’ |
| R: 5’-TTG CTG TAG CCA AAT TCG TTG T- 3 | |
| IL-1b | F: 5’-GAT GCA CCT GTA CGA TCA CT-3’ |
| R: 5’-GAT GCA CCT GTA CGA TCA CT-3’ | |
| IL-8 | F: 5’-AAA TCA GGA AGG CTG CCA AGA-3’ |
| R: 5’-AAG GAA CCA TCT CAC TGT GTG TAA AC-3’ | |
| IL-10 | F: 5’-ACTTTAAGGGTTACCTGGGTTGC-3’ |
| R: 5’-TCACATGCGCCTTGATGTCTG-3’ | |
| PPARa | F: 5’-CCA GTA TTT AGG AAG CTG TCC-3’ |
| R: 5’-AAG TTC TTC AAG TAG CCC TCG-3’ | |
| MOR | F: 5’-GAT CAT GGC CCT CTA CTC CA-3’ |
| R: 5’-TGG TGG CAG TCT TCA TCT TG-3’ | |
| CB2 | F: 5’-GCT AAG TGC CCT GGA GAA CGT-3’ |
| R: 5’- TCA GCC CCA GCC AAG CT-3’ | |
| ZO-1 | F: 5’-AGA GCA ATG GAG GAA ACA GC-3’ |
| R: 5’-CCC CAC TCT GAA AAT GAG GA-3’ | |
| ZO-2 | F: 5’-GGA GCT GTC AGG TTG GCT C-3’ |
| R: 5’-GTC TCT GCC TCC GGA CAC T-3’ | |
| Claudin2 | F: 5’-AAG GCT CTG CAA AGA ACT GC-3’ |
| R: 5’-CTG CCA GGC TGA CTT CTC TC-3’ | |
| MUC2 | F: 5’-CTT CGA CGG ACT CTA CTA CAG C-3’ |
| R: 5’-CTT TGG TGT TGT TGC CAA AC-3’ | |
| MUC5AC | F: 5’-AGAGTGGGAGCTGGGAGAGAG-3’ |
| R: 5’-AGCTCA-GAGGACATATGGGAGGT-3’ |
- Citation: Valibouze C, Dubuquoy C, Chavatte P, Genin M, Maquet V, Modica S, Desreumaux P, Rousseaux C. Chitin-glucan improves important pathophysiological features of irritable bowel syndrome. World J Gastroenterol 2024; 30(16): 2258-2271
- URL: https://www.wjgnet.com/1007-9327/full/v30/i16/2258.htm
- DOI: https://dx.doi.org/10.3748/wjg.v30.i16.2258
